News
These events are associated with innate training and can have long-term impacts on hematopoietic stem and progenitor cell (HSPC) development but can also compromise their function. While many ...
Crown BioScience experts explore organoid models and high-content imaging to evaluate T-cell-targeted therapies and ...
The cells were harvested at various time points and analyzed for signaling and activation markers by flow cytometry. T cells from WT and KO mice were ... of hnRNP L (38), and this was associated with ...
Neoplastic cell morphology in peripheral blood (A) and bone marrow aspirate films (B) showing small- to medium-sized lymphoplasmacytic lymphocytes (May Grunwald Giemsa stain, 1000×). Bone marrow ...
MF9170 is a comprehensive course in flow cytometry for all flow cytometry users. The course covers the basic principles and applications, as well as experimental design and advanced high-parameter ...
Credit: Juan Gaertner via Shutterstock. Chimeric antigen receptor (CAR) T cell therapies have made remarkable strides in treating high-risk B-cell malignancies since the first CAR-T, Novartis’s ...
The report explores innovations in SSBs, SIBs, flow batteries, and fuel cell vehicles, driven by sustainability, cost efficiency, and next-gen mobility needs. It includes ESG perspectives ...
Citation: Successful CAR-T cell therapy for end-stage multiple myeloma using advanced cellular product performed in Hong Kong (2025, March 27) retrieved 20 April 2025 from https://medicalxpress ...
Shuai Chen, MD https://orcid.org/0009-0007-8628-4313 Department of Neurology, The People’s Hospital of Zhengzhou University and Henan Provincial People’s Hospital ...
Chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of refractory or relapsed leukemia and hematologic malignancies, particularly over the past decade. Despite its ...
Nirrin Technologies received U.S. Patent 12,222,279 B2 for its advanced flow-cell technology for in-bioprocess analytics. This patent expands Nirrin’s capabilities in real-time process ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results